DOCSLIB.ORG

2015 Catalog

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2015 Catalog 2015 Catalog Contact and Ordering Information We need the following information to By mail: GenHunter Corporation process an order by fax, phone, or email: 624 Grassmere Park Drive Suite 17 ❑ Billing address Nashville, TN 37211 ❑ Shipping address By Phone: 800-311-8260 or 615-833-0665 ❑ Purchase order / Credit card number By Fax: 615-832-9461 ❑ Name and telephone number of By e-mail: [email protected] persons placing the order [email protected] ❑ Catalog number, description, and Online Ordering: www.GenHunter.com quantity ordered www.DifferentialDisplay.com Terms For your convenience, GenHunter accepts these credit cards: Net 30 days from the date of invoice in U.S. dollars. Conditions of Product Use All products are for research use only. GenHunter disclaims any responsibility for injury or damage that may be caused by the failure of the buyer or any other person to use these products in accordance with the conditions outlined herein. Pricing and Shipping Prices listed are only for the U.S., Canada, & other countries without s and are subject to change without notice. Find distributors outside the U.S. and Canada on page 92 or www.GenHunter.com/distributors. Products are shipped FOB Nashville, TN. Shipping charges are prepaid and added to your invoice. Orders requiring shipment in dry ice are delivered via Federal Express Priority Overnight, Monday through Thursday, unless otherwise requested. Warranty GenHunter warrants that the products will meet specifications listed. Free replacement of any non-conforming products will be made only if GenHunter is notified within 30 days of product receipt. Patent Information The mRNA Differential Display technology is covered by U.S. Patents 5,262,311; 5,599,672; 5,665,547; 5,965,409; Japanese Patent 2843675; and other issued or pending foreign patents exclusively licensed to GenHunter Corporation. Purchase of the RNAimage® and RNAspectra® kits from GenHunter Corporation comes with a sub-license to practice the differential display process. The AP-TAG® Receptor/Ligand Interaction Detection System is covered by US patents 5,554,499 and 5,801,000 licensed to GenHunter Corporation which holds world-wide exclusive rights to the AP-TAG® technology in the field of research applications. Purchase of an AP-TAG® Kit or any pAPtag vector comes with a limited, single-user and non-transferable sublicense for use in research applications only. No part of the kit or pAPtag plasmid vectors shall be disseminated, propagated or distributed outside the user’s own laboratory without written permission from GenHunter. The PCR process is covered by patents owned by Hoffman-La Roche Inc. No license or immunity under any other patent is either granted or implied by the sale of any GenHunter product. Cover photograph: Seashore of Bar Harbor, Maine (by Peng Liang). Catalog Design and Editing: David Turell, Jonathan Meade To our valued customers In 2012, we celebrated the twentieth year since the invention of the award-winning differential display technology. During this time, differential display (DD) has become the most widely used methodology to clone differentially expressed genes. In fact, the number of publications using differential display has exceeded the number of publications using all the other competitive methods. Despite the flurry of interest in DNA microarrays and next-gen sequencing, there have still been more scientists who have published the successful cloning of differentially expressed genes using DD than those who used other techniques. See the Technical Notes Section (page 64) which has more information on advantages of DD over microarray and other competing technologies. In 1998, in recognition of the great impact of DD technology, its inventors, Drs. Peng Liang and Arthur Pardee, were awarded the prestigious Molecular Bioanalytics GenHunter Corporation, Nashville, TN, USA prize by the German Society of Molecular Biology and Biological Chemistry (see page 6). experience and relentless pursuit of perfection in differential display, we are confident that you will be able to obtain more In addition to the sheer number of differentially expressed valuable information on gene expression profiling from us genes cloned by differential display, the biological functions than from any other methodology. of these genes are emerging. GenHunter Corporation is proud to have been the driving force in making this powerful Our AP-TAG® ligand/receptor interaction detection technology within easy reach of biomedical researchers technology (page 43-59) has revolutionized the way cell sur- throughout the world (see the representative references from face receptors and ligands are detected and cloned. This tech- our customers starting on page 71). nology may allow one to further functionally characterize secreted proteins or cell surface molecules cloned by DD or Since 1992, the year when differential display was invented, other methods. GenHunter Corporation has continued to improve, perfect and streamline the technology. Our complete line of Our PerfectWestern® Western blotting line of products innovative products centered around differential display (page 56-57; download more info at www.PerfectWestern.com) technology has made GenHunter synonymous with are designed to save money while producing superior western differential display. These kits include the RNApure® RNA blots. The specially designed PerfectWestern containers isolation system (page 11), our well known MessageClean® are available in 37 sizes and perfectly accommodate western kit for the removal of chromosomal DNA (page 12), the blots of any size: whole blots, half blots, and strips. They RNAimage® kit featuring the third generation of differential significantly reduce the volume of expensive antibodies display technology (page 16), our magic PCR-TRAP® required while still producing beautiful western blots! We cloning system for cloning the PCR amplified cDNA (page also offer pre-cut PerfectMembranes™ in 3 sizes & 30), the HotPrime® DNA probe labeling kit for optimized 4 materials, PerfectFilm™ ECL film, the PerfectRocker™, Northern blot analysis (page 35) and the ReversePrime® The Belly Dancer® shaker, The Belly Button® shaker, and cDNA labeling kit for reverse Northern blot analysis (page PerfectPipettors™. 37) of cDNA fragments identified by differential display. We continue to expand our world-wide market as the The completion of the human genome was undoubtedly a leader in differential display technology. great achievement, however, a much more daunting task is trying to interpret the genomic information in the context of The RNAspectra® Fluorescent Differential Display Kit biology. Because of you, our valued customers, differential (page 20-24) is the only non-radioactive differential display display has been and will continue to be the leading technol- system with similar sensitivity to that of isotope labeling. By ogy for deciphering genomic information for the benefit of translating the great success of our customers using our scientific knowledge and human health. reagent kits, GenHunter is also proud to offer our state-of-the-art Fluorescent Differential Display Service (page 26-29) with complete computerized automation in liquid Best wishes with gene hunting! dispensing and digital fluorescent data capturing with unsurpassed data reproducibility. With our years of From all of us at GenHunter Corporation 800-311-8260 www.GenHunter.com 1 For Orders or Tech Support Table of Contents About GenHunter Corporation .....................................................................................6 About the 1998 Molecular Bioanalytics Award............................................................7 About mRNA Differential Display.................................................................................8 Kits, Reagents, and Services for Differential Display 9 “GenHunter’s Complete System for Differential Display” Outline.....................................................10 RNA Isolation, Cleaning, and Quantification 11 RNApure® Reagent - for total RNA isolation............................................................................................11 RNA Loading Mix - for RNA denaturation and gel analysis....................................................................11 MessageClean® Kit - for removal of DNA contamination from RNA.....................................................12 Individual Components for MessageClean® Kit........................................................................12 MatureMessage™ cRNA Isolation Reagent - for purification of cytoplasmic RNA (cRNA) ................13 Gene Spec™ Micro-Spectrophotometers - for quantification of 1-50µL of RNA/DNA........................14 Differential Display Kits and Services 16 RNAimage® Kits - for radioactive Differential Display ...........................................................................16 Individual Components for RNAimage® Kits ...........................................................................18 Frequently asked questions about the RNAimage® / RNAspectra® Kits.............................................19 RNAspectra® Green Kits - for Fluorescent Differential Display (with Fluorescein) ..............................20 Individual Components for RNAspectra® Green Kits...............................................................24 RNAspectra® Red Kits - for Fluorescent Differential Display (with Rhodamine)..................................22 Individual Components for RNAspectra® Red Kits ..................................................................24
Load more

Recommended publications
  • Anti-Rab11 Antibody (ARG41900)
    Product datasheet [email protected] ARG41900 Package: 100 μg anti-Rab11 antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes Rab11 Tested Reactivity Hu, Ms, Rat, Dog, Mk Tested Application IHC-Fr, IHC-P, WB Host Goat Clonality Polyclonal Isotype IgG Target Name Rab11 Antigen Species Mouse Immunogen Purified recombinant peptides within aa. 110 to the C-terminus of Mouse Rab11a, Rab11b and Rab11c (Rab25). Conjugation Un-conjugated Alternate Names RAB11A: Rab-11; Ras-related protein Rab-11A; YL8 RAB11B: GTP-binding protein YPT3; H-YPT3; Ras-related protein Rab-11B RAB25: RAB11C; CATX-8; Ras-related protein Rab-25 Application Instructions Application table Application Dilution IHC-Fr 1:100 - 1:400 IHC-P 1:100 - 1:400 WB 1:250 - 1:2000 Application Note IHC-P: Antigen Retrieval: Heat mediation was recommended. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Hepa cell lysate Calculated Mw 24 kDa Observed Size ~ 26 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS, 0.05% Sodium azide and 20% Glycerol. Preservative 0.05% Sodium azide www.arigobio.com 1/3 Stabilizer 20% Glycerol Concentration 3 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use.
    [Show full text]
  • North Fork of the St. Lucie River Floodplain Vegetation Technical Report
    NORTH FORK ST. LUCIE RIVER FLOODPLAIN VEGETATION TECHNICAL REPORT WR-2015-005 Coastal Ecosystem Section Applied Sciences Bureau Water Resources Division South Florida Water Management District Final Report July 2015 i Resources Division North Fork of the St. Lucie River Floodplain Vegetation Technical Report ACKNOWLEDGEMENTS This document is the result of a cooperative effort between the Coastal Ecosystems Section of South Florida Water Management District (SFWMD) and the Florida Department of Environmental Protection (FDEP), Florida Park Service (FPS) at the Savannas Preserve State Park in Jensen Beach, Florida and the Indian River Lagoon Aquatic Preserve Office in Fort Pierce, Florida. The principle author of this document was as follows: Marion Hedgepeth SFWMD The following staff contributed to the completion of this report: Cecilia Conrad SFWMD (retired) Jason Godin SFWMD Detong Sun SFWMD Yongshan Wan SFWMD We would like to acknowledge the contributions of Christine Lockhart of Habitat Specialist Inc. with regards to the pre-vegetation plant survey, reference collection established for this project, and for her assistance with plant identifications. We are especially grateful to Christopher Vandello of the Savannas Preserve State Park and Laura Herren and Brian Sharpe of the FDEP Indian River Lagoon Aquatic Preserves Office for their assistance in establishing the vegetation transects and conducting the field studies. And, we would like to recognize other field assistance from Mayra Ashton, Barbara Welch, and Caroline Hanes of SFWMD. Also, we would like to thank Kin Chuirazzi for performing a technical review of the document. ii North Fork of the St. Lucie River Floodplain Vegetation Technical Report TABLE OF CONTENTS Acknowledgements ..........................................................................................................................ii List of Tables ...............................................................................................................................
    [Show full text]
  • Monoclonal Antibodies Against Cd30 Lacking In
    (19) TZZ_97688¥_T (11) EP 1 976 883 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07K 16/28 (2006.01) A61P 35/00 (2006.01) 03.10.2012 Bulletin 2012/40 A61P 37/00 (2006.01) (21) Application number: 07718000.8 (86) International application number: PCT/US2007/001451 (22) Date of filing: 17.01.2007 (87) International publication number: WO 2007/084672 (26.07.2007 Gazette 2007/30) (54) MONOCLONAL ANTIBODIES AGAINST CD30 LACKING IN FUCOSYL AND XYLOSYL RESIDUES MONOKLONALE ANTIKÖRPER GEGEN CD30 OHNE FUCOSYL- UND XYLOSYLRESTE ANTICORPS MONOCLONAUX ANTI-CD30 DEPOURVUS DE RESIDUS FUCOSYL ET XYLOSYL (84) Designated Contracting States: • WANG, Ming-Bo AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Canberra Australian Capital Territory 2617 (AU) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR (74) Representative: Tuxworth, Pamela M. Designated Extension States: J A Kemp RS 14 South Square Gray’s Inn (30) Priority: 17.01.2006 US 759298 P London WC1R 5JJ (GB) 07.04.2006 US 790373 P 11.04.2006 US 791178 P (56) References cited: 09.06.2006 US 812702 P WO-A-03/059282 US-A1- 2004 261 148 11.08.2006 US 837202 P 11.08.2006 US 836998 P • P. BORCHMANN ET AL.: "The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity (43) Date of publication of application: against malignant lymphoma." BLOOD, vol. 102, 08.10.2008 Bulletin 2008/41 no.
    [Show full text]
  • Protein Prenylation Reactions As Tools for Site-Specific Protein Labeling and Identification of Prenylation Substrates
    Protein prenylation reactions as tools for site-specific protein labeling and identification of prenylation substrates Dissertation zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) des Fachbereichs Chemie der Technischen Universität Dortmund Angefertigt am Max-Planck-Institut für molekulare Physiologie in Dortmund Vorgelegt von Dipl.-Chemikerin Thi Thanh Uyen Nguyen aus Jülich Dortmund, April 2009 Die vorliegende Arbeit wurde in der Zeit von Oktober 2005 bis April 2009 am Max-Planck- Institut für molekulare Physiologie in Dortmund unter der Anleitung von Prof. Dr. Roger S. Goody, Prof. Dr. Kirill Alexandrov und Prof. Dr. Herbert Waldmann durchgeführt. 1. Gutachter : Prof. Dr. R. S. Goody 2. Gutachter : Prof. Dr. H. Waldmann The results of this work were published in the following journals: “Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization” U.T.T. Nguyen, J. Cramer, J. Gomis, R. Reents, M. Gutierrez-Rodriguez, R.S. Goody, K. Alexandrov, H. Waldmann, Chembiochem 2007, 8 (4), 408-23. “Development of selective RabGGTase inhibitors and crystal structure of a RabGGTase- inhibitor complex” Z. Guo, Y.W. Wu, K.T. Tan, R.S. Bon, E. Guiu-Rozas, C. Delon, U.T.T. Nguyen, S. Wetzel,S. Arndt, R.S. Goody, W. Blankenfeldt, K. Alexandrov, H. Waldmann, Angew Chem Int Ed Engl 2008, 47 (20), 3747-50. “Analysis of the eukaryotic prenylome by isoprenoid affinity tagging” U.T.T. Nguyen, Z. Guo, C. Delon, Y.W. Wu, C. Deraeve, B. Franzel, R.S. Bon, W. Blankenfeldt, R.S. Goody, H. Waldmann, D. Wolters, K. Alexandrov, Nat Chem Biol 2009, 5 (4), 227-35.
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • A Chemical Proteomic Approach to Investigate Rab Prenylation in Living Systems
    A chemical proteomic approach to investigate Rab prenylation in living systems By Alexandra Fay Helen Berry A thesis submitted to Imperial College London in candidature for the degree of Doctor of Philosophy of Imperial College. Department of Chemistry Imperial College London Exhibition Road London SW7 2AZ August 2012 Declaration of Originality I, Alexandra Fay Helen Berry, hereby declare that this thesis, and all the work presented in it, is my own and that it has been generated by me as the result of my own original research, unless otherwise stated. 2 Abstract Protein prenylation is an important post-translational modification that occurs in all eukaryotes; defects in the prenylation machinery can lead to toxicity or pathogenesis. Prenylation is the modification of a protein with a farnesyl or geranylgeranyl isoprenoid, and it facilitates protein- membrane and protein-protein interactions. Proteins of the Ras superfamily of small GTPases are almost all prenylated and of these the Rab family of proteins forms the largest group. Rab proteins are geranylgeranylated with up to two geranylgeranyl groups by the enzyme Rab geranylgeranyltransferase (RGGT). Prenylation of Rabs allows them to locate to the correct intracellular membranes and carry out their roles in vesicle trafficking. Traditional methods for probing prenylation involve the use of tritiated geranylgeranyl pyrophosphate which is hazardous, has lengthy detection times, and is insufficiently sensitive. The work described in this thesis developed systems for labelling Rabs and other geranylgeranylated proteins using a technique known as tagging-by-substrate, enabling rapid analysis of defective Rab prenylation in cells and tissues. An azide analogue of the geranylgeranyl pyrophosphate substrate of RGGT (AzGGpp) was applied for in vitro prenylation of Rabs by recombinant enzyme.
    [Show full text]
  • Regulatory Mechanisms of Apoptosis in Regularly Dividing Cells
    Cell Health and Cytoskeleton Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Regulatory mechanisms of apoptosis in regularly dividing cells Ribal S Darwish Abstract: The balance between cell survival and death is essential for normal development and Department of Anesthesiology, homeostasis of organisms. Apoptosis is a distinct type of cell death with ultrastructural features Division of Critical Care Medicine, that are consistent with an active, inherently controlled process. Abnormalities and dysregulation University of Maryland Medical of apoptosis contribute to the pathophysiology of multiple disease processes. Apoptosis is strictly Center, Baltimore, Maryland, USA regulated by several positive and negative feedback mechanisms that regulate cell death and determine the final outcome after cell exposure to apoptotic stimuli. Mitochondria and caspases are central components of the regulatory mechanisms of apoptosis. Recently, noncaspase pathways of apoptosis have been explored through the studies of apoptosis-inducing factor and endonu- clease G. Multiple difficulties in the apoptosis research relate to apoptosis detection and imaging. For personal use only. This article reviews current understanding of the regulatory mechanisms of apoptosis. Keywords: caspases, apoptosis-inducing factor, apoptosis inhibitory proteins, cytochrome c, mitochondria Introduction Apoptosis is a distinct type of cell death with ultrastructural features that are con- sistent with an active, inherently controlled process, and it is a part of the necrobio- sis, a process that is essential in maintaining tissue homeostasis. The concept that cells must be lost from the normal tissues to balance their mitotic activity was first proposed by the German anatomist Ludwig Graper,1 who proposed that chromolysis must exist in the cells that will be eliminated.
    [Show full text]
  • US 2017/0020926 A1 Mata-Fink Et Al
    US 20170020926A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0020926 A1 Mata-Fink et al. (43) Pub. Date: Jan. 26, 2017 (54) METHODS AND COMPOSITIONS FOR 62/006,825, filed on Jun. 2, 2014, provisional appli MMUNOMODULATION cation No. 62/006,829, filed on Jun. 2, 2014, provi sional application No. 62/006,832, filed on Jun. 2, (71) Applicant: RUBIUS THERAPEUTICS, INC., 2014, provisional application No. 61/991.319, filed Cambridge, MA (US) on May 9, 2014, provisional application No. 61/973, 764, filed on Apr. 1, 2014, provisional application No. (72) Inventors: Jordi Mata-Fink, Somerville, MA 61/973,763, filed on Apr. 1, 2014. (US); John Round, Cambridge, MA (US); Noubar B. Afeyan, Lexington, (30) Foreign Application Priority Data MA (US); Avak Kahvejian, Arlington, MA (US) Nov. 12, 2014 (US) ................. PCT/US2O14/0653O4 (21) Appl. No.: 15/301,046 Publication Classification (22) PCT Fed: Mar. 13, 2015 (51) Int. Cl. A6II 35/28 (2006.01) (86) PCT No.: PCT/US2O15/02O614 CI2N 5/078 (2006.01) (52) U.S. Cl. S 371 (c)(1), CPC ............. A61K 35/28 (2013.01); C12N5/0641 (2) Date: Sep. 30, 2016 (2013.01): CI2N 5/0644 (2013.01); A61 K Related U.S. Application Data 2035/122 (2013.01) (60) Provisional application No. 62/059,100, filed on Oct. (57) ABSTRACT 2, 2014, provisional application No. 62/025,367, filed on Jul. 16, 2014, provisional application No. 62/006, Provided are cells containing exogenous antigen and uses 828, filed on Jun. 2, 2014, provisional application No.
    [Show full text]
  • New Paradigms in Ras Research Ras Is a Family of Genes Encoding Small Gtpases Involved in Cellular Signal Transduction
    Consultation New paradigms in Ras research Ras is a family of genes encoding small GTPases involved in cellular signal transduction. If their signals are dysregulated, Ras proteins can cause cancer. Dr Sharon Campbell explains her lab’s research into a novel mechanism for regulation of Ras proteins by reactive free radical species Can you explain a little about the activated form and inactivated form of Ras background of your research into Ras, its don’t look all that much different from a aim and where the concept came from? structural standpoint. Although inhibitors that prevent Ras proteins from associating with We had been working on Ras for some the membrane initially appeared promising, time. In the mid-90s there was a group that it was later found that these inhibitors were published an observation that Ras could be not specifi c for Ras. More recent efforts have activated by nitric oxide (NO˙), which is a focused on how other proteins modulate Ras small, highly reactive, radical that turned and targeting those has become an area of out to be the molecule of the year a couple interest. The impact here is that now we’ve of years back because it regulates numerous found a whole host of regulatory factors that cellular processes. So, we followed up because MIKE DAVIS are distinct from protein modulatory factors they had observed this phenomenon in vitro that we can also consider as alternative as well as in cultured cells. We decided to strategies to target Ras. As the altered redox I think the complications are that these redox pursue those observations by testing whether environment in cancer cells may make Ras species are highly reactive and the chemistry we could reproduce it and if so, whether we activity particularly sensitive to redox agents, is complex.
    [Show full text]
  • Modulators of the Function of FAS Receptors and Other Proteins
    (19) *EP002042509A1* (11) EP 2 042 509 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 01.04.2009 Bulletin 2009/14 C07H 21/04 (2006.01) C12N 15/63 (2006.01) C12N 15/85 (2006.01) C12N 15/86 (2006.01) (2006.01) (2006.01) (21) Application number: 08018971.5 C07K 14/00 A61K 39/395 (22) Date of filing: 14.06.1996 (84) Designated Contracting States: (72) Inventors: AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC • Wallach, David NL PT SE 76406 Rehovot (IL) Designated Extension States: • Boldin, Mark AL LT LV SI 76000 Rehovot (IL) • Goncharov, Tanya (30) Priority: 16.07.1995 IL 11461595 76000 Rehovot (IL) 17.08.1995 IL 11498695 • Goltsev, Yury 14.09.1995 IL 11531995 76000 Rehovot (IL) 27.12.1995 IL 11658895 16.04.1996 IL 11793296 (74) Representative: Vossius & Partner Siebertstraße 4 (62) Document number(s) of the earlier application(s) in 81675 München (DE) accordance with Art. 76 EPC: 96919472.9 / 0 914 325 Remarks: This application was filed on 30-10-2008 as a (71) Applicant: YEDA RESEARCH AND divisional application to the application mentioned DEVELOPMENT COMPANY, LTD. under INID code 62. 76 100 Rehovot (IL) (54) Modulators of the function of FAS receptors and other proteins (57) The present invention provides proteins capable ceptor. In addition, peptide inhibitors which interfere with of modulating or mediating the FAS receptor ligand or the proteolytic activity of MORT-1-binding proteins hav- TNF effect on cells carrying FAS receptor or p55 receptor ing proteolytic activity are provided as well as a method by binding or interacting with MORT-1 protein, which in of designing them.
    [Show full text]
  • 1 Women for Sobriety Combined Bibliographies
    Women for Sobriety Combined Bibliographies (June 2016) Compiled by Rita A. Chaney, MS Women for Sobriety Professional Bibliography Abbott, A. A., & Olson, M. (1994). A feminist approach to substance abuse treatment and service delivery. Women’s Health & Social Work, 67-83. Angove, R., & Fothergill, A. (2003, April). Women and alcohol: Misrepresented and misunderstood. Journal of Psychiatric & Mental Health Nursing, 10(2), 213-219. doi: 10.1046/j.1365-2850.2003.00587.x. Atkins, Jr., J. R, & Hawdon, J. E. (2007). Religiosity and participation in mutual-aid support groups for addiction. Journal of Substance Abuse Treatment, 33(3), 321-331. Berenson, D. (1992). Powerlessness—Liberating or enslaving? Responding to the feminist critique of the Twelve Steps. Journal of Feminist Family Therapy, 3(3), 67-84. Bogart, C. J., & Pearce, C. E. (2003). “13th-Stepping:” Why Alcoholics Anonymous is not always a safe place for women. Journal of Addictions Nursing, 14, 43-47. Bond, L. M., & Csordas, T. J. (2014). The paradox of powerlessness. Alcoholism Treatment Quarterly, 32(2-3), 141-156. Chaney, R., & White, W. L. (1992). Metaphors of transformation: Feminine and masculine. Bloomington, IL: Lighthouse Training Institute. Fenner, R.M., & Gifford, M.H. (2012). Women for Sobriety: 35 years of challenges, changes, and continuity. Journal of Groups in Addiction and Recovery, 7(2-4), 142-170. Fenner, R.M., & Gifford, M.H. (2015). Women for Sobriety: An alternative recovery choice. Counselor, 16(4), 18-21. Hafner, S. (1992). Nice girls don’t drink: Stories of recovery. New York, NY: Bergin & Garvey. [An interview of Kirkpatrick]. Hall, M. J., & Tidwell, W.
    [Show full text]
  • Structural Basis of Membrane Trafficking by Rab Family Small G Protein
    Int. J. Mol. Sci. 2013, 14, 8912-8923; doi:10.3390/ijms14058912 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Structural Basis of Membrane Trafficking by Rab Family Small G Protein Hyun Ho Park School of Biotechnology and Graduate School of Biochemistry, Yeungnam University, Gyeongsan 712-749, Korea; E-Mail: [email protected]; Tel.: +82-53-810-3045; Fax: +82-53-810-4769 Received: 1 March 2013; in revised form: 1 April 2013 / Accepted: 10 April 2013 / Published: 25 April 2013 Abstract: The Ras-superfamily of small G proteins is a family of GTP hydrolases that is regulated by GTP/GDP binding states. One member of the Ras-superfamily, Rab, is involved in the regulation of vesicle trafficking, which is critical to endocytosis, biosynthesis, secretion, cell differentiation and cell growth. The active form of the Rab proteins, which contains GTP, can recruit specific binding partners, such as sorting adaptors, tethering factors, kinases, phosphatases and motor proteins, thereby influencing vesicle formation, transport, and tethering. Many Rab proteins share the same interacting partners and perform unique roles in specific locations. Because functional loss of the Rab pathways has been implicated in a variety of diseases, the Rab GTPase family has been extensively investigated. In this review, we summarize Rab GTPase- mediated membrane trafficking while focusing on the structures of Rab protein and Rab-effector complexes. This review provides detailed information that helps explain how the Rab GTPase family is involved in membrane trafficking. Keywords: membrane trafficking; ras-superfamily; small G protein; rab GTPase; protein structure 1.
    [Show full text]